Science-Based Thinking Promises Global Progress On Biosimilars

Samsung Bioepis’ Gillian Woollett Discusses Latest Regulatory Developments

 
• By Dave Wallace
  
Injectable vial biosimilar close-up
Progress for biosimilars is inevitable, assuming a science-based approach, Woollett believes • Source: Shutterstock

More from Biosimilars

More from Products